Search

Author/Creator Coutant, David

1. Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus. Issue 1 (8th September 2016)

Authors:
Linnebjerg, Helle; Lam, Eric Chen Quin; Zhang, Xin; Seger, Mary E.; Coutant, David; Chua, Laiyi; Kapitza, Christoph; Heise, Tim
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 1(2017)
Page Start:
33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels. Issue 6 (21st September 2017)

Authors:
Zhang, Xin; Lam, Eric Chen Quin; Seger, Mary E.; Coutant, David; Chua, Laiyi; Tan, Lai Hock; Soon, Danny; Linnebjerg, Helle
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 6(2017)
Page Start:
556
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study. Issue 10 (18th June 2020)

Authors:
Heise, Tim; Linnebjerg, Helle; Coutant, David; LaBell, Elizabeth; Zijlstra, Eric; Kapitza, Christoph; Bue‐Valleskey, Juliana; Zhang, Qianyi; Dellva, Mary Anne; Leohr, Jennifer
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 10(2020)
Page Start:
1789
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗